방법 비교
선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.
| 소아 피부과 삶의 질 지수(cDLQI)× | SCORAD 지수 (아토피 피부염 점수화)× | |
|---|---|---|
| 분야 | 피부과학 | 피부과학 |
| 계열 | Process / pipeline | Process / pipeline |
| 기원 연도≠ | 1995 | 1993 |
| 창시자≠ | Lewis-Jones MS, Finlay AY | European Task Force on Atopic Dermatitis (ETFAD) |
| 유형≠ | Self-report (parent or child proxy) | Clinician-rated |
| 원전≠ | Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (cDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942-949. DOI ↗ | Kunz B, Oranje AP, Labrèze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-19. DOI ↗ |
| 별칭≠ | cDLQI, Pediatric DLQI | SCORAD Index |
| 관련 | 3 | 3 |
| 요약≠ | The Children's Dermatology Life Quality Index (cDLQI) is a pediatric-adapted version of the adult DLQI, measuring the impact of skin disease on quality of life in children and adolescents aged 4–16 years. Developed by Lewis-Jones and Finlay in 1995, it uses child-friendly language and addresses domains relevant to childhood (school, leisure, friendships, clothing) rather than work and adult relationships. cDLQI is the standard quality-of-life measure in pediatric dermatology trials and clinical practice. | The SCORAD is a comprehensive clinician-administered tool for measuring the extent and severity of atopic dermatitis (eczema). Developed by the European Task Force on Atopic Dermatitis in 1993, it combines objective clinical assessment with subjective symptom reporting. It is the gold standard for atopic dermatitis severity in clinical trials and dermatology practice. |
| ScholarGate데이터셋 ↗ |
|
|